Biolife Solutions Supports Biostorage Through SciSafe's "Centers of Excellence" With New Facility in Amsterdam

Adjacent to the Schiphol Airport in Amsterdam, the facility will include a CAR-T cell storage suite and a freezer farm of 300+ Stirling Ultracold ultra-low temperature ("ULT") freezers for temperature-sensitive biologic material.

Sci Safe 6

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Biolife Solutions, Inc., a supplier of bioproduction tools and services for cell and gene therapies ("CGT"), and its biological material storage brand SciSafe, a multi-facility provider of storage services to the CGT and broader biopharma market, announced the opening of a new 40,000 square-foot biorepository Center of Excellence in Amsterdam, adjacent to the Schiphol Airport.

This facility, already partially contracted to an anchor major pharmaceutical customer, will include a CAR-T cell storage suite to support development of emerging CAR-T cell treatments, boasts a freezer farm of 300+ Stirling Ultracold ultra-low temperature ("ULT") freezers for biopreservation of customers' temperature sensitive biologic material. European pharmaceutical manufacturers are expanding their existing partnerships with SciSafe by utilizing this new Amsterdam storage facility to improve global access to lifesaving biologic therapies. 

"Our SciSafe team has extensive industry experience and expertise in establishing cGMP compliance of cold chain distribution, biostorage protocols, equipment management and sample management," said Michael Rice, chairman and CEO. "We plan to fully leverage our facilities to showcase our tools and services portfolio and to create Centers of Excellence for education and training on CGT bioprocessing workflows."      

SciSafe's state-of-the-art and secure biostorage services allow clients' research teams to focus on what matters most – improving the lives of patients through the discovery of medicines that can prevent, treat and cure some of the world's most life-threatening diseases.

BioLife Solutions is leveraging its biopreservation tools and services portfolio (including Stirling Ultracold freezersIsothermal freezersCryoStor®HypoThermosol® biopreservation media, ThawSTAR® thawing equipmentevo Smart Shippers and Sexton cell processing tools) to define and support biostorage practices. SciSafe facilities hold various quality and regulatory certifications including: ISO20387 and ISO9001, FDA registration, Japan Pharma inspection and Farmatec accreditations.  

Biolife Solutions is committed to ongoing infrastructure investments and innovation to maintain the integrity of stored customer biological and pharmaceutical assets 24/7/365, within its biostorage facilities. Cold storage solutions protect biologic materials in conditions ranging from +70°C to -196°C.

Fill out the form below to request more information about Biolife Solutions Supports Biostorage Through SciSafe's "Centers of Excellence" With New Facility in Amsterdam
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report